Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Spatial Profiling Technologies and Applications for Brain Cancers Publisher Pubmed



Kalitade Croft P1 ; Sadeghi Rad H2 ; Gasper H3, 4 ; Obyrne K5, 6, 7 ; Lakhani SR1, 8 ; Kulasinghe A5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Oncology, Royal Brisbane and Women’s Hospital, Herston, Australia
  4. 4. School of Medicine, University of Queensland, Herston, QLD, Australia
  5. 5. The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University ofTechnology, Woolloongabba, QLD, Australia
  6. 6. Translational Research Institute, Brisbane, QLD, Australia
  7. 7. Princess Alexandra Hospital, Brisbane, QLD, Australia
  8. 8. Pathology Queensland, The Royal Brisbane and Women’s Hospital Herston, QLD, Australia

Source: Expert Review of Molecular Diagnostics Published:2021


Abstract

Introduction: Malignant primary and secondary brain tumors pose a major health challenge, and the incidence of these tumors is rising. The brain tumor microenvironment (TME) is highly complex and thought to impact treatment resistance and failure. To enable a greater understanding of the milieu of cells in the brain TME, advances in imaging and sequential profiling of proteins/mRNA have given rise to the field of spatial transcriptomics. These technologies provide a greater depth of understanding of the tissue architecture, cellular and spatial profiles, including cellular activation status, which may provide insights into effective therapies for brain cancers. Areas Covered: In this review, we provide an overview of spatial profiling technologies at the forefront in the field and describe the applications for brain cancer. Expert opinion: Brain tumors are often resistant to treatment, and display both an immunosuppressive and heterogeneous tumor microenvironment. Next-generation imaging and multi-omics technologies are providing a tool for intricately characterizing their tissue biology. This information will aid in the design of effective therapies and begin to provide an understanding of therapy resistance. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
11. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
14. The Economic Burden of Malignant Brain Tumors, Advances in Experimental Medicine and Biology (2023)
26. Autophagy in Cancers Including Brain Tumors: Role of Micrornas, Cell Communication and Signaling (2020)